Protoplasma

, Volume 63, Issue 1–3, pp 143–146 | Cite as

The effect of prostaglandin E1 on free fatty acid mobilization and transport

  • F. Berti
  • R. Lentati
  • M. M. Usardi
  • R. Paoletti
Contributed Papers I. Phenomena of Membrane Physiology Part C Transport and Drugs

Summary

Prostaglandin E1 (administered by intravenous infusion at the dosis of 5.6μg/kg/min.) (markedly decreases plasma free fatty acids in Sprague-Dawley rats treated with ACTH or norepinephrine or exposed to cold.

The blocking effect is absent in fasted animals, indicating a specific effect of PGE1 on the hormone-activated lipase.

Keywords

Lipase Prostaglandin Free Fatty Acid Norepinephrine PGE1 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Von Euler, U. S., 1934: Arch. Exper. Path. Pharm.175, 78.Google Scholar
  2. [2]
    —, 1939: Skand. Arch. Physiol.81, 65.Google Scholar
  3. [3]
    Bergström, S., R. Ryhage, B. Samuelsson, and J. Sjövall, 1962: Acta Chem. Scand.16, 501.Google Scholar
  4. [4]
    —, F. Dressler, R. Ryhage, B. Samuelsson, and J. Sjövall, 1962: Arkiv. Kemi19, 565.Google Scholar
  5. [5]
    Samuelsson, B., 1965: Angewandte Chemie77, 445.Google Scholar
  6. [6]
    Horton, E. W., 1965: Experientia21, 113.Google Scholar
  7. [7]
    Eliansson, R., 1963: Biochem. Pharm.12, 405.Google Scholar
  8. [8]
    Horton, E. W., and H. M. Main, 1963: Brit. J. Pharm.21, 192.Google Scholar
  9. [9]
    Steinberg, D., M. Vaughan, P. J. Nestel, O. Strand, and S. Bergström, 1964: J. Clin. Invest.43, 1533.Google Scholar
  10. [10]
    Bergström, S., 1965: J. Amer. Oil Chem. Soc.42, 608.Google Scholar
  11. [11]
    Berti, F., and M. M. Usardi, 1964: Giorn. It. Ateroscl.2, 261.Google Scholar
  12. [12]
    Unpublished data.Google Scholar
  13. [13]
    Samuelsson, B., 1964: J. Biol. Chem.239, 4091.Google Scholar
  14. [14]
    Bergström, S., L. A. Carlson, and L. Öro, 1963: Biochem. J.89, 278.Google Scholar
  15. [15]
    — — — 1964: Acta Physiol. Scand.60, 170.Google Scholar
  16. [16]
    Steinberg, D., M. Vaughan, P. J. Nestel, and S. Bergström, 1963: Biochem. Pharm.12, 764.Google Scholar
  17. [17]
    Berti, F., R. Lentati, and M. M. Usardi, 1965: Boll. Soc. It. Biol. Sper. (in press).Google Scholar
  18. [18]
    - - - 1965: Giorn. It. Ateroscl. (in press).Google Scholar
  19. [19]
    Bergström, S., L. A. Carlson, L. G. Ekelund, and L. Öro, 1965: Proc. Soc. Exper. Biol. Med.118, 110.Google Scholar
  20. [20]
    Stern, D. C., and R. P. Maickel, 1963: Life Sciences2, 872.Google Scholar
  21. [21]
    Carlson, L. A., 1965: Proceedings of the 2nd International Symposium on Drugs Affecting Lipid Metabolism, Milan, September.Google Scholar
  22. [22]
    —, 1963: Acta Med. Scand.173, 719.Google Scholar
  23. [23]
    Vertua, R., M. M. Usardi, R. Bombelli, T. Farkas, and R. Paoletti, 1964: Life Sciences3, 281.Google Scholar
  24. [24]
    Farkas, T., R. Vertua, M. M. Usardi, and R. Paoletti, 1964: Life Sciences3, 821.Google Scholar
  25. [25]
    Nikkilä, E. A., and A. Hyvärinen, 1962: Clin. Chim. Acta7, 140.Google Scholar
  26. [26]
    Dole, V. P., 1956: J. Clin. Invest.35, 150.Google Scholar

Copyright information

© Springer-Verlag 1967

Authors and Affiliations

  • F. Berti
    • 1
  • R. Lentati
    • 1
  • M. M. Usardi
    • 1
  • R. Paoletti
    • 1
  1. 1.Institute of PharmacologyUniversity of MilanMilanItaly

Personalised recommendations